Gelteq Limited - Ordinary Shares

Gelteq Limited - Ordinary Shares

Share · AU0000218109 · GELS (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Gelteq Limited - Ordinary Shares
No Price
29.04.2026 19:19
Current Prices from Gelteq Limited - Ordinary Shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GELS
USD
29.04.2026 19:19
0,62 USD
-0,05 USD
-7,76 %
IEXG: IEX
IEX
GELS
USD
23.04.2026 19:58
0,69 USD
-
Company Profile for Gelteq Limited - Ordinary Shares Share
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Company Data

Name Gelteq Limited - Ordinary Shares
Company Gelteq Limited Ordinary Shares
Symbol GELS
Website https://www.gelteq.com
Primary Exchange XNAS NASDAQ
ISIN AU0000218109
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Nathan Jacob Givoni
Country Australia
Currency USD
Employees 0,0 T
Address 641 Glen Huntly Road, 3162 Caulfield
IPO Date 2024-10-29

Ticker Symbols

Name Symbol
NASDAQ GELS
More Shares
Investors who hold Gelteq Limited - Ordinary Shares also have the following shares in their portfolio:
LBBW FZA NH 21/28
LBBW FZA NH 21/28 Bond
LLOYDS BANK PLC FXD RTE FR DL RGE ACC FR RGE NT 03/06/30
LLOYDS BANK PLC FXD RTE FR DL RGE ACC FR RGE NT 03/06/30 Bond